SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 188 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $556,342 | +595.4% | 627,926 | +1135.0% | 0.00% | – |
| Q3 2022 | $80,000 | -88.0% | 50,844 | -82.3% | 0.00% | -100.0% |
| Q1 2022 | $668,000 | +507.3% | 286,694 | +1885.1% | 0.00% | – |
| Q3 2021 | $110,000 | -74.4% | 14,442 | -67.4% | 0.00% | -100.0% |
| Q2 2021 | $429,000 | -84.3% | 44,314 | -86.6% | 0.00% | -87.5% |
| Q1 2021 | $2,741,000 | +966.5% | 331,392 | +780.4% | 0.02% | +700.0% |
| Q4 2020 | $257,000 | -63.5% | 37,643 | -40.4% | 0.00% | -77.8% |
| Q3 2020 | $704,000 | +1000.0% | 63,175 | +517.8% | 0.01% | +800.0% |
| Q2 2020 | $64,000 | -16.9% | 10,225 | -75.7% | 0.00% | -50.0% |
| Q1 2020 | $77,000 | -85.9% | 42,000 | -74.0% | 0.00% | -33.3% |
| Q4 2019 | $545,000 | +1918.5% | 161,262 | +1085.6% | 0.00% | +200.0% |
| Q2 2017 | $27,000 | -65.8% | 13,602 | -15.6% | 0.00% | -66.7% |
| Q4 2016 | $79,000 | – | 16,116 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paloma Partners Management Co | 3,775,000 | $1,359,000 | 0.05% |
| Oaktree Fund Advisors, LLC | 66,000 | $23,760 | 0.02% |
| GoalVest Advisory LLC | 32,915 | $11,849 | 0.01% |
| Houlihan Financial Resource Group, Ltd. | 30,000 | $11 | 0.01% |
| Granite Bay Wealth Management, LLC | 22,520 | $8 | 0.01% |
| S&T BANK/PA | 38,853 | $14 | 0.00% |
| Lattice Capital Management, LLC | 51,800 | $18,648 | 0.00% |
| Modus Advisors, LLC | 19,706 | $7,094 | 0.00% |
| Crescent Grove Advisors, LLC | 60,000 | $21,600 | 0.00% |
| SlateStone Wealth, LLC | 21,433 | $8 | 0.00% |